Weybridge
Surrey
KT13 0NY
Director Name | Mr Lee Di Pietro |
---|---|
Date of Birth | November 1986 (Born 37 years ago) |
Nationality | Australian |
Status | Current |
Appointed | 04 March 2022(2 years, 3 months after company formation) |
Appointment Duration | 2 years, 1 month |
Role | Accountant |
Country of Residence | United Kingdom |
Correspondence Address | Building 5, First Floor The Heights Weybridge Surrey KT13 0NY |
Director Name | GSK Consumer Healthcare Holdings No.4 Limited (Corporation) |
---|---|
Status | Current |
Appointed | 01 April 2022(2 years, 4 months after company formation) |
Appointment Duration | 2 years |
Correspondence Address | 980 Great West Road Brentford Middlesex TW8 9GS |
Director Name | GSK Consumer Healthcare Holdings No.8 Limited (Corporation) |
---|---|
Status | Current |
Appointed | 01 April 2022(2 years, 4 months after company formation) |
Appointment Duration | 2 years |
Correspondence Address | 980 Great West Road Brentford Middlesex TW8 9GS |
Director Name | Mr Antrinkos Andrew Aristidou |
---|---|
Date of Birth | June 1968 (Born 55 years ago) |
Nationality | British |
Status | Resigned |
Appointed | 02 December 2019(same day as company formation) |
Role | Chartered Accountant |
Country of Residence | United Kingdom |
Correspondence Address | 980 Great West Road Brentford TW8 9GS |
Director Name | Mr David John Cottam |
---|---|
Date of Birth | April 1963 (Born 61 years ago) |
Nationality | British |
Status | Resigned |
Appointed | 10 March 2020(3 months, 1 week after company formation) |
Appointment Duration | 1 year, 11 months (resigned 04 March 2022) |
Role | Finance Director |
Country of Residence | England |
Correspondence Address | 980 Great West Road Brentford TW8 9GS |
Director Name | Edinburgh Pharmaceutical Industries Limited (Corporation) |
---|---|
Status | Resigned |
Appointed | 02 December 2019(same day as company formation) |
Correspondence Address | 980 Great West Road Brentford TW8 9GS |
Director Name | Glaxo Group Limited (Corporation) |
---|---|
Status | Resigned |
Appointed | 02 December 2019(same day as company formation) |
Correspondence Address | 980 Great West Road Brentford TW8 9GS |
Registered Address | Building 5, First Floor The Heights Weybridge Surrey KT13 0NY |
---|---|
Region | South East |
Constituency | Runnymede and Weybridge |
County | Surrey |
Ward | Weybridge St George's Hill |
Built Up Area | Greater London |
Address Matches | Over 20 other UK companies use this postal address |
Latest Accounts | 31 December 2022 (1 year, 3 months ago) |
---|---|
Next Accounts Due | 30 September 2024 (5 months, 1 week from now) |
Accounts Category | Full |
Accounts Year End | 31 December |
Latest Return | 24 May 2023 (11 months, 1 week ago) |
---|---|
Next Return Due | 7 June 2024 (1 month, 1 week from now) |
7 November 2023 | Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022 (2 pages) |
---|---|
30 June 2023 | Full accounts made up to 31 December 2022 (24 pages) |
16 June 2023 | Company name changed gsk canada holding company LIMITED\certificate issued on 16/06/23
|
5 June 2023 | Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022 (1 page) |
5 June 2023 | Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022 (1 page) |
5 June 2023 | Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022 (2 pages) |
25 May 2023 | Confirmation statement made on 24 May 2023 with updates (4 pages) |
17 May 2023 | Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023 (1 page) |
17 May 2023 | Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023 (1 page) |
25 November 2022 | Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022 (2 pages) |
3 October 2022 | Full accounts made up to 31 December 2021 (24 pages) |
15 August 2022 | Director's details changed for Mr Lee Di Pietro on 7 July 2022 (2 pages) |
18 July 2022 | Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022 (1 page) |
24 May 2022 | Confirmation statement made on 24 May 2022 with no updates (3 pages) |
8 April 2022 | Statement by Directors (1 page) |
8 April 2022 | Resolutions
|
8 April 2022 | Solvency Statement dated 06/02/22 (1 page) |
8 April 2022 | Statement of capital on 8 April 2022
|
6 April 2022 | Termination of appointment of Glaxo Group Limited as a director on 1 April 2022 (1 page) |
6 April 2022 | Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 1 April 2022 (1 page) |
6 April 2022 | Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 1 April 2022 (2 pages) |
6 April 2022 | Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 1 April 2022 (2 pages) |
9 March 2022 | Termination of appointment of David John Cottam as a director on 4 March 2022 (1 page) |
9 March 2022 | Appointment of Mr Lee Di Pietro as a director on 4 March 2022 (2 pages) |
14 December 2021 | Confirmation statement made on 1 December 2021 with no updates (3 pages) |
2 November 2021 | Full accounts made up to 31 December 2020 (23 pages) |
23 December 2020 | Confirmation statement made on 1 December 2020 with updates (4 pages) |
17 August 2020 | Appointment of Mr Thomas Ian Whittle as a director on 31 July 2020 (2 pages) |
13 August 2020 | Termination of appointment of Antrinkos Andrew Aristidou as a director on 31 July 2020 (1 page) |
18 March 2020 | Appointment of Mr. David John Cottam as a director on 10 March 2020 (2 pages) |
30 December 2019 | Statement of capital following an allotment of shares on 13 December 2019
|
2 December 2019 | Incorporation Statement of capital on 2019-12-02
|